STOCK TITAN

Evolent announces key appointments to leadership team

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

Evolent Health (NYSE: EVH) announced two key leadership appointments to strengthen its clinical and financial teams. Dr. David Lim joins as chief clinical officer, bringing extensive experience in value-based care and healthcare technology. He will lead Evolent's 300-person medical team and report to CMO Dr. Von Nguyen.

John Way has been appointed as CFO of Performance Suite, overseeing financial aspects of the company's at-risk specialty condition management products. Way brings over 20 years of executive financial experience, including roles as CFO at OptumHealth and OptumCare, and will report to CFO John Johnson.

Evolent Health (NYSE: EVH) ha annunciato due importanti nomine dirigenziali per rafforzare i suoi team clinico e finanziario. Il dottor David Lim entra come chief clinical officer, portando una vasta esperienza nella cura basata sul valore e nella tecnologia sanitaria. Guidarà il team medico di 300 persone di Evolent e risponderà al CMO, il dottor Von Nguyen.

John Way è stato nominato CFO di Performance Suite, con la responsabilità degli aspetti finanziari dei prodotti di gestione delle condizioni specialistiche a rischio dell'azienda. Way vanta oltre 20 anni di esperienza finanziaria a livello dirigenziale, inclusi ruoli come CFO presso OptumHealth e OptumCare, e riporterà al CFO John Johnson.

Evolent Health (NYSE: EVH) anunció dos nombramientos clave en su liderazgo para fortalecer sus equipos clínico y financiero. El Dr. David Lim se incorpora como director clínico, aportando amplia experiencia en atención basada en el valor y tecnología sanitaria. Liderará el equipo médico de 300 personas de Evolent y reportará al CMO, el Dr. Von Nguyen.

John Way ha sido nombrado CFO de Performance Suite, supervisando los aspectos financieros de los productos de gestión de condiciones especializadas con riesgo de la empresa. Way cuenta con más de 20 años de experiencia ejecutiva financiera, incluyendo cargos como CFO en OptumHealth y OptumCare, y reportará al CFO John Johnson.

Evolent Health (NYSE: EVH)는 임상 및 재무팀 강화를 위해 두 명의 주요 리더십 임명을 발표했습니다. David Lim 박사가 최고 임상 책임자로 합류하여 가치 기반 진료 및 헬스케어 기술 분야에서 폭넓은 경험을 제공합니다. 그는 Evolent의 300명 의료 팀을 이끌며 최고 의료 책임자인 Von Nguyen 박사에게 보고할 예정입니다.

John Way는 Performance Suite의 CFO로 임명되어 회사의 위험 기반 전문 질환 관리 제품의 재무 측면을 총괄합니다. Way는 OptumHealth와 OptumCare에서 CFO를 역임하는 등 20년 이상의 재무 경영 경험을 보유하고 있으며 CFO John Johnson에게 보고할 예정입니다.

Evolent Health (NYSE : EVH) a annoncé deux nominations clés pour renforcer ses équipes cliniques et financières. Le Dr David Lim rejoint l'entreprise en tant que directeur clinique principal, apportant une vaste expérience dans les soins basés sur la valeur et la technologie de santé. Il dirigera l'équipe médicale de 300 personnes d'Evolent et reportera au directeur médical, le Dr Von Nguyen.

John Way a été nommé directeur financier (CFO) de Performance Suite, supervisant les aspects financiers des produits de gestion des conditions spécialisées à risque de l'entreprise. Way possède plus de 20 ans d'expérience financière à des postes de direction, notamment en tant que CFO chez OptumHealth et OptumCare, et reportera au CFO John Johnson.

Evolent Health (NYSE: EVH) hat zwei wichtige Führungspositionen besetzt, um seine klinischen und finanziellen Teams zu stärken. Dr. David Lim tritt als Chief Clinical Officer bei und bringt umfangreiche Erfahrung in wertorientierter Versorgung und Gesundheitstechnologie mit. Er wird das 300-köpfige medizinische Team von Evolent leiten und dem CMO Dr. Von Nguyen berichten.

John Way wurde zum CFO von Performance Suite ernannt und übernimmt die finanzielle Verantwortung für die risikobasierten Produkte des Unternehmens im Bereich der spezialisierten Krankheitsmanagements. Way verfügt über mehr als 20 Jahre Führungserfahrung im Finanzbereich, unter anderem als CFO bei OptumHealth und OptumCare, und wird an CFO John Johnson berichten.

Positive
  • None.
Negative
  • None.
  • Dr. David Lim joins Evolent as chief clinical officer
  • John Way joins Evolent as CFO, Performance Suite

WASHINGTON, July 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced leadership additions to its clinical and financial teams, as it continues to drive innovation in specialty care.

Physician, executive and startup entrepreneur Dr. David Lim has joined the company as chief clinical officer, where he will lead Evolent's 300-person medical team to support daily operations and innovation. Dr. Lim brings deep experience in value-based care, technology-enabled healthcare and patient engagement. Before joining Evolent, he served as chief medical officer (CMO) of RightMove Health, a virtual physical therapy company he helped to grow from the ground up as its first employee. Dr. Lim has also served as chief technology innovation officer for value-based care company InnovaCare Health, founding team member and CMO of behavioral health company Quartet Health, and director of clinical design for Castlight Health, which provided healthcare services cost and quality data to members of self-insured employers.

Additionally, John Way has joined Evolent as CFO, Performance Suite, where he will oversee all financial aspects of the company's at-risk specialty condition management products. Mr. Way brings more than 20 years of executive financial management experience to the role, including as CFO of OptumHealth and OptumCare. He combines deep subject matter expertise in risk-based value arrangements with an innovator's perspective to drive success for Evolent and its partners.

"I'm excited to welcome Dave and John, not just because of their deep experience but also their commitment to transforming specialty care for patients, payers and providers," said Evolent CEO and Co-Founder Seth Blackley. "As these additions show, Evolent remains a leading destination for talented and accomplished leaders in our field."

Dr. Lim will report to Chief Medical Officer Dr. Von Nguyen, while Mr. Way will report to CFO John Johnson.

Evolent Health Logo (PRNewsfoto/Evolent Health)

About Evolent  
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.

Media inquiries 

media@evolent.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-announces-key-appointments-to-leadership-team-302500645.html

SOURCE Evolent Health, Inc.

FAQ

Who are the new executives joining Evolent Health (EVH)?

Dr. David Lim joins as chief clinical officer to lead the 300-person medical team, and John Way joins as CFO of Performance Suite to oversee specialty condition management products.

What is Dr. David Lim's background before joining Evolent Health?

Dr. Lim previously served as CMO of RightMove Health, chief technology innovation officer at InnovaCare Health, CMO at Quartet Health, and director of clinical design at Castlight Health.

What experience does John Way bring to Evolent Health?

John Way brings over 20 years of executive financial management experience, including serving as CFO of OptumHealth and OptumCare, with expertise in risk-based value arrangements.

Who will the new Evolent Health executives report to?

Dr. David Lim will report to Chief Medical Officer Dr. Von Nguyen, while John Way will report to CFO John Johnson.
Evolent Health Inc

NYSE:EVH

EVH Rankings

EVH Latest News

EVH Latest SEC Filings

EVH Stock Data

1.37B
115.69M
2.72%
107.42%
12.18%
Health Information Services
Services-management Services
Link
United States
ARLINGTON